POSTDOCTORAL
2018 - 2023. Postdoctoral Associate followed by Research Scientist (Medical Scientist).
Research Foundation for The State University of New York (SUNY) at Stony Brook, e-mail.
100 Nicolls Rd S5422 Melville Library, Stony Brook, 11794 NY, US.
2023 -2023 Research Scientist at the Department of Family, Population & Preventive Medicine, Division of Cancer Prevention, SUNY at Stony Brook Medicine (SBM), New York, USA. Specialized in cancer research, with a focus on the molecular mechanisms of paclitaxel-induced neuropathic pain (PIPN) in a mouse model. Conducted transcriptome analysis in mice, investigated neuronal differentiation, and studied axonal transport in cell cultures. Prioritized completing postdoctoral projects and publications (2018–2023: 7 articles, multiple transcriptome datasets and nucleotide records).
2021 -2023 Postdoctoral Associate at the Department of Family, Population & Preventive Medicine, Division of Cancer Prevention, SUNY at SBM. Specialized in cancer genetics and development of anti-cancer drugs (efficacy, toxicity, targets and molecular action). Conducted research using high-throughput next-generation technologies, transcriptomics, pharmacogenomics, bioinformatics, cell cultures, animal models (mouse, rat), Patient-Derived Xenografts (PDXs), and investigated the role of inflammation and immune response in PIPN.
2020 -2021 Postdoctoral Associate at the Department of Ophthalmology, Division of Cancer Prevention, SUNY at SBM. Specialized in medical biotechnology innovations for research on the molecular aspects of dry eye disease (DED), including improved ocular impression cytology (IC), quantitative cell transfer from IC to microscope slides, and primary cornea, conjunctiva human cell cultures on nitrocellulose scaffolds for ex-vivo drug evaluation. Conducted studies on inflammation and immune responses in DED using animal models (rabbits), transcriptomics.
20018 -2020 Postdoctoral Associate at the Department of Medicine, Division of Cancer Prevention, SUNY at SBM. Specialized in cancer research, drug synthesis and drug development. Conducted large-scale data analysis, including kinome profiling, Whole Genome Sequencing (WGS), and Pharmacoscan, to identify alterations potentially contributing to drug resistance (pharmacogenomics). Chemical synthesis of drugs and their modifications, followed by analysis using spectroscopy, NMR, and mass spectrometry, subsequently tested in cell cultures, animal models (mouse), PDXs.
DOCTORAL, PhD, dr med. sc.
2005 - 2016. PhD Student, followed by Research Scientist.
The Centre of Postgraduate Medical Education in Warsaw (CMKP), Doctoral Studies: email, www.
Marymoncka 99/103, 01-813 Warsaw, Poland, EU.
2005 -2010 5-year full-time doctoral studies at Department of Biochemistry and Molecular Biology, CMKP in the field of medical biology focusing on cancer research under the supervision of Professor Alicja Nauman, PhD. Doctoral dissertation: The Role of Untranslated Regions (UTRs) in the Expression of the T3-Dependent Nuclear Thyroid Hormone Receptor β1 (TRβ1) in Human Clear Cell Renal Cell Carcinoma (ccRCC).
2010 -2016 Research Scientist focused on managing multiple cancer research grants and authoring 11 scientific articles. Defended a doctoral dissertation, awarded the academic degree of Doctor of Medical Sciences in Medical Biology on 30/03/2016.
The work* was performed at The Center of Postgraduate Medical Education in Warsaw, Poland in cooperation with DNAi Biotech Lab and Imperial College London. *Selected publications: publication-1, publication-2, publication-3.
Bachelor of Engineering, Engineer
2001 - 2004. Engineering Student.
Cracow University of Technology (PK), Chemical Engineering and Technology.
Warszawska 24, 31-155 Krakow, PL, EU.
2001 -2004 Four-year studies at Faculty of of Chemical Engineering and Technology, Institute of Organic Chemistry and Technology of PK in collaboration with the Institute of Biotechnology and Antibiotics in Warsaw (now Institute of Industrial Chemistry). Field: light chemical synthesis, biotechnology and genetic engineering. Engineer’s thesis: Engineering of a Plasmid-Based Genetic Construct Encoding the Fusion Protein: Ubiquitin-Ubiquitin Protease 4. The project was part of the purification method development for insulin production technology. Completed studies in Chemical Technology with a specialization in Light Organic Technology, graduating in 2004 and earning the title of Engineer.
Master of Science, M.sc.
1996 - 2001. Master of Science Student.
Jagiellonian University in Krakow (UJ), founded in 1364, ranked first in Poland
Golebia 24, 31-007 Krakow, PL, EU.
1996 -2001 Five-year full-time studies at the Faculty of Biochemistry, Biophysics, and Biotechnology (FBBB), Department of Cell Biology (CB), Jagiellonian University (UJ). Master's thesis: The Influence of Extracellular Calcium Ions on Contact-Mediated Acceleration of Migration of Mouse Melanoma B16 Cells. Completed in the field of Biology with a specialization in Molecular Biology, graduating in 2001 and earning the title of M.Sc.
2001 -2003 License to practice the profession of a laboratory diagnostician no. AA04465, issued by the National Chamber of Laboratory Diagnosticians, Number of entry on the list of laboratory diagnosticians: 08989. The license was obtained based on laboratory experience after Masters degree.
Institution: National Chamber of Laboratory Diagnosticians. Address: ul. Konopacka 4 , 03-428 Warsaw, PL, EU. Contact: email, website.
2023 - present (2025). Completing a specialization program in the Field of Health Care: Medical Molecular Genetics (continuous postgraduate (professional) education).
Institution: The Centre of Postgraduate Medical Education in Warsaw, PL, EU. Address: Marymoncka 99/103, 01-813 Warsaw, Poland, EU. Contact: email, website.
2024 -present. Member of the Scientific Advisory Board and Business Advisor at Gednasa LLC, New York City, US.
Role: Engaged in preparatory activities for the start-up GeDNAsa LLC, focusing on strategic planning, market research, and scientific discussions to establish operations. Key areas of interest include a) Genomic signatures for personalized medicine, aimed at recruiting cancer patients for clinical trials based on driver mutations through an AI-driven platform offering molecular diagnostics, targeted therapy identification, and trial matching using resources like clinicaltrials.gov. b) RNA-based therapeutics (eRNA). c) Quantum biology exploring ways to modulate cellular processes and drug metabolism using quantum phenomena. Non-work-related collaboration. Additionally, collaborating with DNAi – The Center of Genetic Information (PL) on EU-US consortium projects in precision medicine.
2018 - 2023 Postdoctoral Associate followed by Research Scientist (Medical Scientist) SOC Code: 19-1042.00 at Research Foundation for The State University of New York (SUNY) at Stony Brook NAICS code: 541714. 100 Nicolls Rd S5422 Melville Library, Stony Brook, 11794 NY, US.
2023 -2023 Conducted studies as a Research Scientist in the Department of Family, Population & Preventive Medicine, Division of Cancer Prevention, SUNY, Stony Brook Medicine (SBM). Focused on finalizing research projects and publications initiated during the postdoctoral period, including work in cancer research, ophthalmic research, and inflammation and immune response pathways. For further details, see Academic Experience.
2021 -2023 Postdoctoral Associate at the Department of Family, Population & Preventive Medicine, Division of Cancer Prevention, SUNY Stony Brook Medicine (SBM). Specialized in cancer genetics and drug development.
2020 -2021 Postdoctoral Associate, Department of Ophthalmology, SUNY, SBM. Conducted ophthalmic research, developed biotechnology innovations for dry eye disease (DED). See References for details.
2018 -2020 Postdoctoral Associate, Department of Medicine, SUNY, SBM. Cancer research, drug development, chemical synthesis of drugs, pharmacogenomics, in-vivo, in-vitro, ex-vivo studies. See Academic Experience.
2014 - 2017 Scientific Director of the laboratory of genetics and biochemistry at DNAi - The Centre of Genetic Information. Baltycka 3, 31-214 Krakow, PL, EU.
Lab leader, geneticist, and court expert specializing in genetics and biochemistry, with expertise in forensic sciences and genetic diagnostics for precision molecular medicine. Conducted bioinformatic analyses of genetic data both on-site (2014–2017) and remotely as a scientific advisor (2018–2022, non-work-related activity). Collaborated with academia on scientific projects, including studies on translational control in cancer. Designed and led training programs and summer sessions in molecular biology, forensic genetics, medical biology, and medical biotechnology, mentoring student groups completing company fellowships funded by the Polish Ministry of Funds and Regional Policy and EU grants.
2005 - 2016 PhD Student followed by Research Scientist at The entre of Postgraduate Medical Education in Warsaw (CMKP), Marymoncka 99/103, 01-813 Warsaw, PL, EU.
2005 -2010 Conducted research as a PhD student at the Department of Biochemistry and Molecular Biology, CMKP, in the field of medical biology, focusing on renal cancer (ccRCC) genetics and translational control.
2010 -2016 Research Scientist (non-work related) focused on managing multiple cancer research grants and authoring scientific articles. Awarded the academic degree of Doctor of Medical Sciences in Medical Biology. See Academic Experience.
2005 - 2014 The Founder & CEO, Scientific Project Director at BioTe21, Laboratory of Molecular Medical Biology, NZOZ BioTe21 (Non-Public Healthcare Institution). Case study of BioTe21. Gronostajowa 7, 30-387 Krakow, PL, EU.
Organized BioTe21, a spin-off of the Jagiellonian University (UJ), affiliated with the Jagiellonian Center of Innovation and the Center for Technology Transfer UJ CITTRU. Secured funding through grant proposals, including the Integrated Regional Operational Program (IROP) and the 7th European Union Framework Programme (FP7). Designed the infrastructure for a genetic laboratory and a Non-Public Healthcare Institution (NZOZ). Developed innovative biotechnologies for molecular diagnostics, in vitro gene synthesis, a novel method for protein translation enhancement, and nucleotide-based next-generation therapeutics (eRNA/dGoligo, see Patents). Conducted routine genetic and biochemical testing for molecular medicine, academia, and forensic sciences, including DNA/RNA synthesis, sequencing, genomics, and transcriptomics. The company was later restructured to align with evolving market demands, enabling me to focus on my PhD dissertation and 11 scientific publications (see References).
2005 - 2008 Member of the Scientific Advisory Board, and Laboratory Designer Nucleagena sp. z o.o (now Synevo Sp. z o.o), Pawinskiego 5A, 02-106 Warsaw, PL, EU.
The role involved designing and establishing a laboratory for molecular diagnostics and diagnostic devices, writing and managing scientific projects funded by European Structural Funds, and implementing advanced technologies for medical diagnostics, including genetic testing for microbiological infections such as HPV, Chlamydia, Legionella, and Toxoplasma, and cytology.
2003 - 2005. Molecular Biologist and Laboratory Diagnostician at The Institute for DNA Research in Warsaw (2005). Rakowiecka 36 lok. 30a, 02-532 Warsaw, PL, EU.
The role involved laboratory diagnostics, including DNA/RNA analysis, Sanger sequencing, genetic paternity testing, sorting of fetal erythroblasts, and preparing genetic constructs for recombinant proteins.
2002 - 2003. Biologist at Nencki Institute of Experimental Biology, Laboratory of molecular neurobiology. Pasteura 3, 02-093 Warsaw PL, EU.
Conducted research at the Laboratory of Transcription Regulation, applying various molecular biology methods such as gene cloning, gene expression analysis, and studies on TGF-β as a key regulator of glioblastoma invasion, with findings published in Oncogene (Nature).
2002 - 2002. Molecular Biologist. Institute for DNA Research in Warsaw (2002). Rakowiecka 36 lok. 30a, 02-532 Warsaw, PL, EU.
The role involved supporting the organization of a molecular biology laboratory, including DNA sequencing, STR analysis, and genetic analyses for forensic sciences.
2001 - 2002. Biologist. Institute of Farmacology of Polish Academy of Science, Department of Molecular Neuropharmacology. Smetna 12, 31-343 Krakow, PL, EU.
Conducted research at the Department of Molecular Neuropharmacology, utilizing molecular biology techniques, cell culture, and gene expression profiling, with a focus on drug abuse and neurobiology.
SUMMARY
Fields of expertise based on the North American Industry Classification System (NAICS):
Research and Development in Biotechnology (541714),
Research and Development in … Life Sciences (541715).
Profession based on the Standard Occupational Classification (SOC):
Medical Scientist (19-1042.00),
Research Scientist (19-1029.00, 19-1099.00),
Laboratory diagnostician (29-2011.00),
Chemical Engineer (17-2041.00).
Biology: Medical biology, medical biotechnology, molecular biology, cancer research (in vitro, ex vivo and in vivo animal models), bioinformatics, genomics, transcriptomics, proteomics, laboratory diagnostics, laboratory medical genetics.
Chemistry: chemical engineering, biochemistry, biotechnology of recombinant proteins, synthesis of anticancer drugs, molecular targeting, drug discovery and development.
Physics (future direction): quantum mechanics, quantum biology, quantum medicine (genomics, drug discovery, precision medicine).